Literature DB >> 24081382

Monetite and brushite coated magnesium: in vivo and in vitro models for degradation analysis.

Shaylin Shadanbaz1, Jemimah Walker, Tim B F Woodfield, Mark P Staiger, George J Dias.   

Abstract

The use of magnesium (Mg) as a biodegradable metallic replacement of permanent orthopaedic materials is a current topic of interest and investigation. The appropriate biocompatibility, elastic modulus and mechanical properties of Mg recommend its suitability for bone fracture fixation. However, the degradation rates of Mg can be rapid and unpredictable resulting in mass hydrogen production and potential loss of mechanical integrity. Thus the application of calcium phosphate coatings has been considered as a means of improving the degradation properties of Mg. Brushite and monetite are utilized and their degradation properties (alongside uncoated Mg controls) are assessed in an in vivo subcutaneous environment and the findings compared to their in vitro degradation behaviour in immersion tests. The current findings suggest monetite coatings have significant degradation protective effects compared to brushite coatings in vivo. Furthermore, it is postulated that an in vitro immersion test may be used as a tentative predictor of in vivo subcutaneous degradation behavior of calcium phosphate coated and uncoated Mg.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24081382     DOI: 10.1007/s10856-013-5059-2

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  55 in total

1.  Calcium phosphate bone cements for clinical applications. Part I: solution chemistry.

Authors:  E Fernández; F J Gil; M P Ginebra; F C Driessens; J A Planell; S M Best
Journal:  J Mater Sci Mater Med       Date:  1999-03       Impact factor: 3.896

Review 2.  Biomedical coatings on magnesium alloys - a review.

Authors:  H Hornberger; S Virtanen; A R Boccaccini
Journal:  Acta Biomater       Date:  2012-04-14       Impact factor: 8.947

3.  Characterization of electrolytically prepared brushite and hydroxyapatite coatings on orthopedic alloys.

Authors:  J Redepenning; T Schlessinger; S Burnham; L Lippiello; J Miyano
Journal:  J Biomed Mater Res       Date:  1996-03

4.  Deriving tissue density and elastic modulus from microCT bone scans.

Authors:  David W Wagner; Derek P Lindsey; Gary S Beaupre
Journal:  Bone       Date:  2011-07-23       Impact factor: 4.398

5.  Passive and active in vitro resorption of calcium and magnesium phosphate cements by osteoclastic cells.

Authors:  Christian Grossardt; Andrea Ewald; Liam M Grover; Jake E Barralet; Uwe Gbureck
Journal:  Tissue Eng Part A       Date:  2010-08-30       Impact factor: 3.845

Review 6.  The history of biodegradable magnesium implants: a review.

Authors:  Frank Witte
Journal:  Acta Biomater       Date:  2010-02-19       Impact factor: 8.947

7.  Silver/hydroxyapatite composite coatings on porous titanium surfaces by sol-gel method.

Authors:  Jie Qu; Xiong Lu; Dan Li; Yonghui Ding; Yang Leng; Jie Weng; Shuxin Qu; Bo Feng; Fumio Watari
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2011-02-02       Impact factor: 3.368

8.  Hydroxyapatite coating on magnesium with MgF₂ interlayer for enhanced corrosion resistance and biocompatibility.

Authors:  Ji-Hoon Jo; Bong-Gyu Kang; Kwang-Seon Shin; Hyoun-Ee Kim; Byung-Dong Hahn; Dong-Soo Park; Young-Hag Koh
Journal:  J Mater Sci Mater Med       Date:  2011-09-10       Impact factor: 3.896

Review 9.  Calcium/calmodulin signaling controls osteoblast growth and differentiation.

Authors:  Majd Zayzafoon
Journal:  J Cell Biochem       Date:  2006-01-01       Impact factor: 4.429

10.  Influence of surface modification on the in vitro corrosion rate of magnesium alloy AZ31.

Authors:  Joy E Gray-Munro; Christine Seguin; Michael Strong
Journal:  J Biomed Mater Res A       Date:  2009-10       Impact factor: 4.396

View more
  6 in total

Review 1.  Applications and perspectives of nanomaterials in novel vaccine development.

Authors:  Yingbin Shen; Tianyao Hao; Shiyi Ou; Churan Hu; Long Chen
Journal:  Medchemcomm       Date:  2017-10-17       Impact factor: 3.597

2.  Improvement of bioactivity, degradability, and cytocompatibility of biocement by addition of mesoporous magnesium silicate into sodium-magnesium phosphate cement.

Authors:  Yingyang Wu; Xiaofeng Tang; Jie Chen; Tingting Tang; Han Guo; Songchao Tang; Liming Zhao; Xuhui Ma; Hua Hong; Jie Wei
Journal:  J Mater Sci Mater Med       Date:  2015-09-22       Impact factor: 3.896

3.  Comparison of Selective Laser Melted Titanium and Magnesium Implants Coated with PCL.

Authors:  Julia Matena; Svea Petersen; Matthias Gieseke; Michael Teske; Martin Beyerbach; Andreas Kampmann; Hugo Murua Escobar; Nils-Claudius Gellrich; Heinz Haferkamp; Ingo Nolte
Journal:  Int J Mol Sci       Date:  2015-06-10       Impact factor: 5.923

4.  Osteointegration of Porous Poly-ε-Caprolactone-Coated and Previtalised Magnesium Implants in Critically Sized Calvarial Bone Defects in the Mouse Model.

Authors:  Michael Grau; Christian Seiler; Laura Roland; Julia Matena; Claudia Windhövel; Michael Teske; Hugo Murua Escobar; Matthias Lüpke; Hermann Seifert; Nils-Claudius Gellrich; Heinz Haferkamp; Ingo Nolte
Journal:  Materials (Basel)       Date:  2017-12-21       Impact factor: 3.623

5.  3D gel-printed porous magnesium scaffold coated with dibasic calcium phosphate dihydrate for bone repair in vivo.

Authors:  Yuxuan Zhang; Tao Lin; Haoye Meng; Xueting Wang; Hong Peng; Guangbo Liu; Shuai Wei; Qiang Lu; Yu Wang; Aiyuan Wang; Wenjing Xu; Huiping Shao; Jiang Peng
Journal:  J Orthop Translat       Date:  2022-02-03       Impact factor: 5.191

6.  Poly-ε-caprolactone Coated and Functionalized Porous Titanium and Magnesium Implants for Enhancing Angiogenesis in Critically Sized Bone Defects.

Authors:  Laura Roland; Michael Grau; Julia Matena; Michael Teske; Matthias Gieseke; Andreas Kampmann; Martin Beyerbach; Hugo Murua Escobar; Heinz Haferkamp; Nils-Claudius Gellrich; Ingo Nolte
Journal:  Int J Mol Sci       Date:  2015-12-22       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.